Skip to main content
Clinical Trials/NCT01318772
NCT01318772CompletedNot Applicable

Clinical Image Evaluation for the KALARE (DREX-KL80) With New Digital Camera and Image Processor

Toshiba America Medical Systems, Inc.1 site in 1 country42 target enrollmentStarted: December 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
42
Locations
1
Primary Endpoint
Collection of representative images

Study Overview

Brief Summary

The purpose of this study is to acquire the clinical data required by the United States Food and Drug Administration (USFDA) for 510(k) submission, for approval of a new high resolution imaging system for fluoroscopy/radiography. It is expected that the new KALARE (DREX-KL80)high resolution imaging system will meet the design specifications. A minimum of 30 cases will be submitted for evaluation of claims for intended clinical applications.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Male and female patient 18 years and older
  • Not pregnant
  • Not a safety risk patient

Exclusion Criteria

  • Male and female patient under 18 years old
  • Pregnant subjects
  • High safety risk subjects
  • Subjects and/or Legal Guardian Unable to provide informed consent

Outcomes

Primary Outcomes

Collection of representative images

Time Frame: Estimated completion 4 weeks after start of the study

Collect 30 to 60 represenative images to support pre-market submission.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials

Clinical Image Evaluation for the... | Clinical Trial